Thyroid Disorders in Saudi Patients With Acromegaly: A Tertiary Care Center Experience.

Moayad A Alsuraikh, Eyad Almalki, Tuqa Bazuhair, Mussa Almalki
Author Information
  1. Moayad A Alsuraikh: Obesity, Endocrine, and Metabolism Center, King Fahad Medical City, Riyadh, SAU.
  2. Eyad Almalki: College of Medicine, Shaqra University, Shaqra, SAU.
  3. Tuqa Bazuhair: Obesity, Endocrine, and Metabolism Center, King Fahad Medical City, Riyadh, SAU.
  4. Mussa Almalki: Obesity, Endocrine, and Metabolism Center, King Fahad Medical City, Riyadh, SAU.

Abstract

Background Acromegaly is a rare disease that is frequently associated with thyroid diseases. The exact prevalence of goiter and thyroid dysfunction remains uncertain. Objectives This study aims to provide a comprehensive description of the clinical, morphological, and biochemical features of thyroid disorder in Saudi patients with acromegaly and to establish its correlation with the activity and duration of the disease. Methods This retrospective study involved patients who were diagnosed with acromegaly during the period 2006-2023 in an outpatient endocrine clinic at a tertiary hospital. Results A total of 40 patients with acromegaly (27 males and 13 females) were identified and included in the analysis, with a mean age of 46.78 ± 13.76 years and an estimated duration of disease of 8.08 ± 6.43 years. Goiter was diagnosed in 28 patients (70.0%), including multinodular goiter (MNG) (70.0%), solitary thyroid nodules (14.2%), and thyroid cysts (14.2%). Primary hypothyroidism was present at 40.0%. Goiter was not correlated with estimated insulin-like growth factor 1 (IGF-1) levels or disease duration. In 40 patients with nodular goiter, fine needle biopsies were performed in six cases; five nodules were benign, and one nodule was a follicular lesion of unknown significance (Bethesda III). Conclusions The patients with acromegaly have a high prevalence of nodular thyroid disorders and thyroid dysfunction. No cases of thyroid cancer were found in our study. The periodic ultrasonography assessment of the thyroid is needed for evaluating patients with acromegaly.

Keywords

References

  1. Arch Endocrinol Metab. 2020 May-Jun;64(3):269-275 [PMID: 32555993]
  2. J Clin Endocrinol Metab. 2007 Oct;92(10):4039-45 [PMID: 17666480]
  3. J Prim Care Community Health. 2022 Jan-Dec;13:21501319221095345 [PMID: 35465762]
  4. Arq Bras Endocrinol Metabol. 2012 Jul;56(5):300-4 [PMID: 22911282]
  5. Eur J Endocrinol. 2009 Oct;161(4):607-13 [PMID: 19666699]
  6. Cancer Causes Control. 2002 Jun;13(5):395-400 [PMID: 12146843]
  7. Clin Diabetes Endocrinol. 2020 Nov 17;6(1):24 [PMID: 33292786]
  8. Endocr Rev. 2004 Feb;25(1):102-52 [PMID: 14769829]
  9. PLoS One. 2014 Feb 14;9(2):e88787 [PMID: 24551163]
  10. Horm Metab Res. 2000 May;32(5):190-5 [PMID: 10871160]
  11. Pituitary. 2010 Sep;13(3):242-8 [PMID: 20217483]
  12. Exp Clin Endocrinol Diabetes. 2004 May;112(5):225-30 [PMID: 15146366]
  13. Pituitary. 2015 Dec;18(6):912-5 [PMID: 26163018]
  14. Horm Metab Res. 1991 Mar;23(3):131-4 [PMID: 1907592]
  15. Endocr Res. 2005;31(1):51-8 [PMID: 16238191]
  16. J Clin Endocrinol Metab. 1989 Sep;69(3):639-47 [PMID: 2547829]
  17. Endocrinology. 1990 Feb;126(2):736-45 [PMID: 2404747]
  18. Clin Endocrinol (Oxf). 2005 Aug;63(2):161-7 [PMID: 16060909]
  19. J Clin Endocrinol Metab. 1988 Nov;67(5):973-8 [PMID: 3053751]
  20. Arch Endocrinol Metab. 2016 Nov-Dec;60(6):554-561 [PMID: 27982201]
  21. J Assoc Physicians India. 2019 Oct;67(10):29-32 [PMID: 31571448]
  22. Pituitary. 2013 Mar;16(1):109-14 [PMID: 22527615]
  23. Growth Horm IGF Res. 2021 Oct-Dec;60-61:101431 [PMID: 34740022]
  24. Arq Bras Endocrinol Metabol. 2013 Dec;57(9):685-90 [PMID: 24402013]
  25. J Endocrinol Invest. 2002;25(10 Suppl):66-8 [PMID: 12508922]
  26. Endocr Rev. 1989 May;10(2):125-35 [PMID: 2666115]
  27. Arq Bras Endocrinol Metabol. 2005 Oct;49(5):843-9 [PMID: 16444369]
  28. J Endocrinol Invest. 2002 Mar;25(3):240-5 [PMID: 11936466]
  29. J Clin Endocrinol Metab. 2000 Feb;85(2):526-9 [PMID: 10690849]
  30. Endocr J. 2008 Mar;55(1):67-71 [PMID: 18202526]
  31. J Clin Endocrinol Metab. 1999 Mar;84(3):829-34 [PMID: 10084556]
  32. Clin Endocrinol (Oxf). 1997 May;46(5):545-9 [PMID: 9231049]

Word Cloud

Created with Highcharts 10.0.0thyroidpatientsacromegalydiseasegoiterdysfunctionstudyduration400%nodulesprevalenceSaudidiagnosed13±yearsestimated70142%nodularcasescancerultrasonographyBackgroundAcromegalyrarefrequentlyassociateddiseasesexactremainsuncertainObjectivesaimsprovidecomprehensivedescriptionclinicalmorphologicalbiochemicalfeaturesdisorderestablishcorrelationactivityMethodsretrospectiveinvolvedperiod2006-2023outpatientendocrineclinictertiaryhospitalResultstotal27malesfemalesidentifiedincludedanalysismeanage467876808643 Goiter28includingmultinodularMNGsolitarycystsPrimaryhypothyroidismpresentGoitercorrelatedinsulin-likegrowthfactor1IGF-1levelsfineneedlebiopsiesperformedsixfivebenignonenodulefollicularlesionunknownsignificanceBethesdaIIIConclusionshighdisordersfoundperiodicassessmentneededevaluatingThyroidDisordersPatientsAcromegaly:TertiaryCareCenterExperienceghigf-1autoimmunity

Similar Articles

Cited By